Transforming Primary Care for Lesbian, Gay, Bisexual, and Transgender People
Wednesday, December 16, 2020
12:00 PM PST
By the end of this presentation, participants will be able to…
- Describe three disparities in access to care and health outcomes LGBTQ+ patients experience.
- Identify data which can be collected, monitored, and evaluated to enhance culturally affirming care for LGBTQ+ patients.
- Summarize three initiatives that have been shown to enhance culturally affirming care for LGBTQ+ patients.
This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.
Bruce W. Furness, MD, MPH, FACPM (“Bryce”)
Is a Medical Epidemiologist in CDC’s Division of STD Prevention who has been embedded in the Washington, DC Department of Health since 2002. He has acted in many different capacities: as the Acting Chief, Division of STD Control; as the Chief Medical Officer (CMO), Southeast STD & TB Control and Chest Clinics; and, currently, as the Strategic Information Division’s STD Medical Epidemiologist. Highlights of his tenure include starting and evaluating the District’s Internet Partner Notification (IPN) Program, helping start and manage the District’s School-based STD Screening Program, starting and running Whitman-Walker Health’s (WWH) Transgender Health Clinic, helping run WWH’s Gay Men’s Health & Wellness Clinic, and acting as the CMO of the DC Health and Wellness Center’s PrEP Clinic. He is a subject matter expert on LGBT health, was part of the National Coalition of STD Directors (NCSD) and the National Alliance of State and Territorial AIDS Directors (NASTAD) Blue Ribbon Panel of experts for the “MSM Sexual Health Standards of Care,” and is a member of the National Coalition for Sexual Health’s Health Care Action Group advocating for adding a 6th “P” to sexual history taking. Bryce has recently published two journal articles stemming from a multi-organization multi-year collaboration to improve the sexual health of LGBT patients attending community health centers.
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards and the Washington Medical Commission. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Federation of State Medical Boards designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Alden Roberts, MD
Washington Medical Commission
This learning activity is not funded by any commercial entity.
However, the Washington Medical Commission gratefully acknowledges the unrestricted educational grant from the FSMB Foundation in the amount of $10,000 to support this activity.
Disclosure of Commercial Interest
As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity and promote improvements or quality in healthcare. All persons in the position to control the content of an education activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.
The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity.
The speakers, course director and planners at the Federation of State Medical Boards and the Washington Medical Commission have no relevant financial interests to disclose.
Disclosure of Unlabeled Uses
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.
Faculty and Staff Disclosures
No speakers or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.